Alloimmune Disorders of Pregnancy: Anaemia, Thrombocytopenia and Neutropenia in the Fetus and Newborn

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  2005-08-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-3148.2002.00397.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [Point mutation].

  2019cited by this paper
• Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.

  2008cited by this paper
• The detection of anti-granulocyte antibodies by chemiluminescence.

  2008cited by this paper
• Assignment of the leucocyte group five surface antigens to human chromosome 4.

  2008cited by this paper
• NE1: a new neutrophil specific antigen.

  2008cited by this paper
• Management of alloimmune thrombocytopenia

  2007cited by this paper
• Demonstration von fetalem Hämoglobin in den Erythrocyten eines Blutausstrichs

  2005cited by this paper
• Correspondence of the monocyte antigen HMA-1 to the non-HLA antigen 9a

  2004cited by this paper
• FETAL AND NEONATAL EDITION ARCHIVES OF DISEASE IN CHILDHOOD

  2004cited by this paper
• Biallelic Neutrophil Na-Antigen System Is Associated With a Polymorphism on the Phospho-Inositol-Linked Fcy Receptor 111 (CD16)

  2003cited by this paper
• Neonatal alloimmune neutropenia due to anti-HNA-1b.

  2002cited by this paper
• Single amino acid substitution in human platelet glycoprotein Ibβ is responsible for the formation of the platelet-specific alloantigen Iya

  2000cited by this paper
• A MULTI-CENTRE TRIAL OF MONOCLONAL ANTI-D IN THE PREVENTION OF RH-IMMUNIZATION OF RHD- MALE VOLUNTEERS BY RHD+ RED CELLS

  2000cited by this paper
• Neutrophil antigen 5b is carried by a protein, migrating from 70 to 95 kDa, and may be involved in neonatal alloimmune neutropenia

  2000cited by this paper
• Neonatal thrombocytopenia induced by maternal anti-HLA antibodies: a potential side effect of allogenic leukocyte immunization for unexplained recurrent aborters.

  2000cited by this paper
• Murine monoclonal antibodies reactive with a human monoclonal anti‐RhD antibody (BRAD‐5)

  2000cited by this paper
• RHD gene deletion occurred in the Rhesus box.

  2000cited by this paper
• Neonatal thrombocytopenia in two of six human platelet alloantigen (HPA) 5a‐positive children of an HPA‐5a‐immunized mother

  2000cited by this paper
• Preparation and storage characteristics of white cell‐reducedhigh‐concentration platelet concentrates collected by anapheresis system for transfusions in utero

  2000cited by this paper
• B‐lymphoblastoid cell lines as a source of reference DNA for human platelet and neutrophil antigen genotyping

  2000cited by this paper
• Genomic characterization of the Kidd blood group gene:different molecular basis of the Jk(a–b–) phenotypein Polynesians and Finns

  2000cited by this paper
• Evaluation of the Safety of Rh Immunoglobulin by Monitoring Viral Markers among Rh–Negative Female Blood Donors

  2000cited by this paper
• Blood Transfusion in Clinical Medicine, 10th edition

  1999cited by this paper
• Management and Outcome of Fetomaternal Rh Alloimmunization in Twin Pregnancies

  1999cited by this paper
• A new splenic artery Doppler velocimetric index for prediction of severe fetal anemia associated with Rh alloimmunization.

  1999cited by this paper
• Recommendations for the use of anti‐D immunoglobulin for Rh prophylaxis

  1999cited by this paper
• Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemia cells.

  1999cited by this paper
• Evaluation of an enzyme‐linked immunosorbent assay kit (GTI PakPlus®) for the detection of antibodies against human platelet antigens

  1999cited by this paper
• Non‐invasive RNA‐based determination of fetal Rhesus D type: a prospective study based on 96 pregnancies

  1999cited by this paper
• Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years.

  1999cited by this paper
• Neutrophil antibody specificity in different types of childhood autoimmune neutropenia.

  1999cited by this paper
• Transmission Rates of Hepatitis C Virus by Different Batches of a Contaminated Anti‐D Immunoglobulin Preparation

  1999cited by this paper
• Anti–Granulocyte Antibody Screening with Extracted Granulocyte Antigens by a Micro–Mixed Passive Hemagglutination Method

  1999cited by this paper
• Nomenclature of Granulocyte Alloantigens

  1999cited by this paper
• Microsatellite Variation within the Human RHCE Gene

  1999cited by this paper
• The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1

  1999cited by this paper
• Prevention of transfusion‐transmitted cytomegalovirus infection

  1999cited by this paper
• Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT)

  1999cited by this paper
• Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.

  1999cited by this paper
• Monitoring the clearance of fetal RhD‐positive red cells in FMH following RhD immunoglobulin administration

  1999cited by this paper
• Proteolytic processing of big endothelin-3 by the kell blood group protein.

  1999cited by this paper
• Site‐directed mutagenesis of the human D antigen: definition of D epitopes on the sixth external domain of the D protein expressed on K562 cells

  1999cited by this paper
• A prospective study of routine antenatal enzyme antibody screening demonstrates lack of clinical value in predicting haemolytic disease of the newborn

  1999cited by this paper
• Mapping the site on human IgG for binding of the MHC class I‐related receptor, FcRn

  1999cited by this paper
• Evaluation by enzyme‐linked immunosorbent assay of IgG anti‐D and IgG subclass concentrations in immunoglobulin preparations

  1999cited by this paper
• Human Fetal and Maternal Noradrenaline Responses to Invasive Procedures

  1999cited by this paper
• Rapid clearance of fetal DNA from maternal plasma.

  1999cited by this paper
• Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia

  1999cited by this paper
• Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease.

  1998cited by this paper
• The scientific basis of antenatal prophylaxis

  1998cited by this paper
• Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases.

  1998cited by this paper
• Rh phenotype prediction by DNA typing and its application to practice

  1998cited by this paper
• Detection of fetal messenger ribonucleic acid in maternal blood to determine fetal RhD status as a strategy for noninvasive prenatal diagnosis.

  1998cited by this paper
• Fetal Splenic Size in Anemia Due to Rh‐alloimmunization

  1998cited by this paper
• Molecular insights into blood groups and implications for blood transfusion

  1998cited by this paper
• FcR-mediated inhibition of cell activation and other forms of coinhibition.

  1998cited by this paper
• Assessment of the clinical usefulness of the ‘Queenan’ chart versus the ‘Liley’ chart in predicting severity of rhesus iso‐immunization

  1998cited by this paper
• Clinical Aspects and Typing of Platelet Alloantigens

  1998cited by this paper
• Economics of antenatal prophylaxis

  1998cited by this paper
• Genomic typing of the Kidd blood group locus by a single‐tube allele‐specific primer PCR technique

  1998cited by this paper
• Superclustering of B cell receptor and Fc gamma RIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1.

  1998cited by this paper
• Hemolytic Disease of the Fetus: A Comparison of the Queenan and Extended Liley Methods

  1998cited by this paper
• Prognostic Factors and Management in Pregnancies Complicated with Severe Kell Alloimmunization: Experiences of the Last 13 Years

  1998cited by this paper
• Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

  1998cited by this paper
• A recombinant soluble form of the integrin alpha IIb beta 3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies.

  1998cited by this paper
• New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion.

  1998cited by this paper
• The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn

  1998cited by this paper
• Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IVIgG and steroids.

  1998cited by this paper
• Detection of fetal RHD-specific sequences in maternal plasma.

  1998cited by this paper
• RHD Gene Polymorphisms among RhD‐Negative Chinese in Taiwan

  1998cited by this paper
• Use of the gel agglutination technique for determination of fetomaternal hemorrhage

  1998cited by this paper
• Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.

  1998cited by this paper
• Human RhDel is caused by a deletion of 1,013 bp between introns 8 and 9 including exon 9 of RHD gene.

  1998cited by this paper
• Current practice in neonatal exchange transfusions: a retrospective audit based at one transfusion centre

  1998cited by this paper
• The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.

  1998cited by this paper
• Neonatal Alloimmune Thrombocytopenia Associated With Maternal Anti‐HLA Antibody: A Case Report

  1998cited by this paper
• Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay

  1998cited by this paper
• RhD hemolytic disease of the newborn.

  1998influential reference
• Anti‐D immunoglobulin in RhD prophylaxis

  1998cited by this paper
• A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele‐specific primers

  1998cited by this paper
• Management of Fetal and Neonatal Alloimmune Thrombocytopenia

  1998cited by this paper
• IgG‐Fc‐mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation

  1998cited by this paper
• The RhD- trait in a white patient with the RhCCee phenotype attributed to a four-nucleotide deletion in the RHD gene.

  1998cited by this paper
• Prospective non‐invasive monitoring of pregnancies complicated by red cell alloimmunization

  1998cited by this paper
• Feto‐maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids — more questions than answers

  1998cited by this paper
• HPA-10w(b) (La(a)): genetic determination of a new platelet-specific alloantigen on glycoprotein IIIa and its expression in COS-7 cells.

  1997cited by this paper
• Molecular Basis of Kell Blood Group Phenotypes

  1997cited by this paper
• FcRn: the MHC class I-related receptor that is more than an IgG transporter.

  1997cited by this paper
• The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility.

  1997cited by this paper
• Differences between RhD-negative Africans and RhD-negative Europeans.

  1997cited by this paper
• An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses.

  1997cited by this paper
• Prenatal detection of rhesus D genotype.

  1997cited by this paper
• Immunoglobulin G subclasses of anti‐human platelet antigen la in maternal sera: relation to the severity of neonatal alloimmune thrombocytopenia

  1997cited by this paper
• Graft Versus Host Disease Following Intrauterine and Exchange Transfusions for Rhesus Haemolytic Disease

  1997cited by this paper
• Maternal immunization to Gov system alloantigens on human platelets

  1997cited by this paper
• RHD/CE typing by polymerase chain reaction using sequence‐specific primers

  1997cited by this paper
• Clinical uses of intravenous immunoglobulin in pregnancy.

  1997cited by this paper
• Increase of fetal hematocrit decreases the middle cerebral artery peak systolic velocity in pregnancies complicated by rhesus alloimmunization.

  1997cited by this paper
• A randomised controlled trial of feedback to general practitioners of their prophylactic aspirin prescribing

  1997cited by this paper
• High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease

  1997cited by this paper

• Anti-D Antibody Prevalence and Its Role in Hemolytic Disease Among Fetuses and Neonates in Erbil City

  2025cites this paper
• Feasibility for non‐invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing: A single test system for multiple atypical red cell, platelet and quality control markers

  2023cites this paper
• Identification and management of fetal anemia due to hemolytic disease

  2022cites this paper
• RHD Genotypes in a Chinese Cohort of Pregnant Women

  2021cites this paper
• M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model.

  2019cites this paper
• Cell-free DNA fetal blood group testing for RhD-negative pregnant women: Implications for midwifery

  2016cites this paper
• Use of cffDNA to avoid administration of anti‐D to pregnant women when the fetus is RhD‐negative: implementation in the NHS

  2015cites this paper
• Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility

  2013cites this paper
• Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section

  2012cites this paper
• Prevention of RhD alloimmunization in RhD negative women.

  2010cites this paper
• Detection and prevention of pregnancy immunisation : the OPZI study Koelewijn

  2009cites this paper
• Detection and prevention of pregnancy immunisation : the OPZI study

  2009cites this paper
• Newborn illnesses caused by transplacental antibodies.

  2008cites this paper
• Management of Rhesus Alloimmunization in Pregnancy

  2002cites this paper
• High-risk Pregnancy Series: an Expert's View Management of Rhesus Alloimmunization in Pregnancy

  year unknowncites this paper